EcoDrugPlus

Cholecystokinin A Receptor

Ensembl ID : ENSECRG00000003953
Gene Symbol: CCKAR
3 Cross references
201 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSECRG00000003834
Gene Symbol: CCKBR
3 Cross references
270 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSECRG00000020505
Gene Symbol: LOC114666458
2 Cross references
257 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSECRG00000020429
Gene Symbol: LOC114667126
2 Cross references
257 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSECRG00000014334
Gene Symbol: LOC114644985
2 Cross references
257 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSECRG00000006548
Gene Symbol: CETP
3 Cross references
151 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSECRG00000001022
Gene Symbol: CHRM2
3 Cross references
261 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSECRG00000014350
Gene Symbol: CHRM3
1 Cross references
257 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSECRG00000004899
Gene Symbol: CHRM4
3 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSECRG00000022490
Gene Symbol: CHRM5
3 Cross references
264 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSECRG00000022109
Gene Symbol: CHRNA3
1 Cross references
202 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 2 Subunit

Ensembl ID : ENSECRG00000004714
Gene Symbol: CHRNB2
1 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).